Curative Intent — Cancer Treatment Goals

Curative intent is a clinical classification defining the therapeutic objective of a treatment plan. Rather than managing symptoms or slowing down advanced disease progression, treatment planned with curative intent aims to permanently remove or destroy all cancer cells within the body. This approach typically applies to localised or regionally confined tumours that have not metastasised to distant anatomical sites.

Achieving this goal often requires multimodal therapy, bringing together surgical resection, radiation therapy, and systemic treatments such as chemotherapy or immunotherapy. While the clinical intent is complete eradication, healthcare teams acknowledge that microscopic cells may remain undetected, requiring ongoing surveillance even after treatment concludes.

Understanding whether your care is delivered with curative intent helps you make informed choices about your treatment plan. Because the aim is long-term survival, you and your medical team may agree that enduring short-term side effects or intensive interventions is worthwhile. Clarifying this goal ensures realistic expectations, aligns your personal values with the proposed therapies, and provides a clear framework for measuring success during follow-up scans and consultations.

Determining whether a patient is a candidate for curative-intent treatment requires thorough baseline staging. This involves imaging modalities such as CT, MRI, and PET scans to confirm that the cancer has not spread distantly. Pathological assessments, including tumour grading, surgical margin evaluations, and genetic or protein biomarkers (such as HER2, ER/PR, or microsatellite instability), further clarify tumour behaviour and confirm eligibility for intensive, focused protocols.

Curative intent most often applies to early-stage and locally advanced malignancies. Common examples include stage I to III breast cancer, localised colorectal cancer, early-stage non-small cell lung cancer, and early prostate cancer. It is also the standard approach for several systemic cancers, including Hodgkin lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukaemia, where systemic therapy alone can achieve lasting remissions.

Curative-intent regimens frequently combine several modalities to maximise the chance of complete eradication. A typical regimen may involve radical surgery to remove the primary tumour, combined with neoadjuvant or adjuvant systemic therapies to destroy circulating cells. Definitive chemoradiotherapy is another curative approach used when surgery is not feasible. Post-treatment care involves structured surveillance to detect any early recurrence promptly.